scispace - formally typeset
R

Raphael Mechoulam

Researcher at Hebrew University of Jerusalem

Publications -  469
Citations -  51302

Raphael Mechoulam is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Cannabinoid & Cannabinoid receptor. The author has an hindex of 105, co-authored 452 publications receiving 46664 citations. Previous affiliations of Raphael Mechoulam include Weizmann Institute of Science & Tel Aviv University.

Papers
More filters
Journal ArticleDOI

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

TL;DR: In this article, an arachidonylethanthanolamide (anandamide) was identified in a screen for endogenous ligands for the cannabinoid receptor and its structure was determined by mass spectrometry and nuclear magnetic resonance spectroscopy and confirmed by synthesis.
Journal ArticleDOI

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

TL;DR: It is considered premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, because pharmacological evidence for the existence of additional types of cannabinoid receptor is emerging and other kinds of supporting evidence are still lacking.
Journal ArticleDOI

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

TL;DR: In this paper, the extinction coefficients of stilbene, stil bene-, and stilben-2 were determined for tetrahydrofuran, 2-methyltetrahydrlfurfh-fragments, and 1,2-dime thoxye thane.
Journal ArticleDOI

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

TL;DR: This review summarizes current data indicating the extent to which cannabinoid receptor ligands undergo orthosteric or allosteric interactions with non- CB1, non-CB2 established GPCRs, deorphanized receptors such as GPR55, ligand-gated ion channels, transient receptor potential (TRP) channels, and other ion channels or peroxisome proliferator-activated nuclear receptors.